Welcome to Day Four of the Conversation: #AIDS2026 from Rio de Janeiro.

In partnership with Gilead Sciences, Plus Life is proud to bring powerful conversations with advocates, scientists, experts, community leaders, researchers, and more to the forefront of HIV prevention and treatment.

Science builds the tools. Community makes them real.

Day 4 at #AIDS2026: Karl Schmid sits down with Gilead’s Jane Stafford, Larkin Callaghan, and The Positive Fund’s Harley Nascimento to talk about why community has always led the HIV response – and why that’s not changing anytime soon.

Plus, Gilead’s Rashad Burgess breaks down what it actually takes to build partnerships that move the needle.

Data tells us what and where. Community tells us how.

Join the movement to turn positive into a plus and follow us everywhere: @PlusLifeMedia